The domestic nine-valent HPV vaccine "Xinkening 9" is launched in Xiamen, with more advantageous prices
Recently, the domestic nine-valent HPV vaccine "Xinkening 9" was officially launched in Xiamen, attracting widespread attention. As the first approved nine-valent HPV vaccine in China, its price advantage is significant and provides more economical and affordable preventive options for women of appropriate age. The following are detailed data and hot topic analysis about the vaccine.
1. Core data of the domestic nine-valent HPV vaccine "Xinkening 9"
| project | data |
|---|---|
| Vaccine name | Xinkening 9 |
| R&D companies | Xiamen Wantai Canghai Biotechnology Co., Ltd. |
| Approval time | April 2024 |
| Applicable age | Women aged 9-45 |
| Inoculation doses | 3 needles (0, 2, 6 months) |
| Single needle price | About 1,100 yuan (imported nine-price is about 1,300 yuan) |
| Covering virus type | HPV 6, 11, 16, 18, 31, 33, 45, 52, 58 |
2. Price advantages of domestic nine-valent HPV vaccine
Compared with the imported nine-valent HPV vaccine, the price of "Xinkening 9" single shot is reduced by about 15%, and the entire vaccination can save about 600 yuan. Here is the price comparison:
| Vaccine Type | Single needle price (yuan) | Full process fee (yuan) |
|---|---|---|
| Domestic nine-valent (Xinkening 9) | 1100 | 3300 |
| Imported nine-price (MSD) | 1300 | 3900 |
3. The significance of vaccination of domestic nine-valent HPV vaccine
1.Reduce the incidence of cervical cancer: HPV vaccine is an effective means to prevent cervical cancer, and the popularity of domestic nine-valent vaccines will significantly increase vaccination coverage.
2.Easing supply and demand contradictions: There is a long-term supply in short supply of imported nine-valent vaccines, and the mass production of domestic vaccines will alleviate the situation of "hard to find a vaccine".
3.Promote the research and development of domestic vaccines: The approval marks a breakthrough in my country in the field of high-end vaccines, and more domestic vaccines may be released in the future.
4. Analysis of the relationship between hot topics on the entire network in the past 10 days
Through the review of hot content on the entire network for the past 10 days, it was found that the following topics are highly related to "Xinkening 9":
| Ranking | Related topics | Popularity index |
|---|---|---|
| 1 | Domestic nine-valent HPV vaccine is on the way | 985,000 |
| 2 | HPV vaccine price comparison | 762,000 |
| 3 | Guidelines for women's health prevention | 658,000 |
| 4 | Progress in research and development of domestic vaccines | 534,000 |
5. Expert advice and precautions for vaccination
1.Priority for vaccination: Women aged 9-15 who have not had sex are the best, and women aged 26-45 still need to be vaccinated.
2.Taboo people: People who are allergic to vaccine ingredients and women during pregnancy should be temporarily postponed.
3.Reaction after vaccination: Slight reactions such as local redness, swelling, low fever, etc., which may be relieved on their own in 2-3 days.
6. Future prospects
With the promotion of "Xinkening 9" in more cities across the country, it is expected that the production of domestic nine-valent HPV vaccines will exceed 10 million doses in 2024. The National Health Commission said that HPV vaccine will be gradually included in the immunization plan to further reduce vaccination costs. The rise of domestic vaccines not only brings benefits to the people, but also demonstrates the innovative capabilities of my country's biopharmaceutical industry.
check the details
check the details
en
